Kasniunas, NinaMills, Lindsey2018-04-062018-04-062017http://hdl.handle.net/11603/7922Julia Rogers Research Prize: Junior/Senior WinnerApproximately 133 million Americans live with a chronic illness (“The Power of Prevention”). Government funding through the National Institutes of Health and other programs are an important source of research funding for the doctors and scientists who study and treat these diseases and syndromes. I am one of those Americans and live with a disease that very few doctors specialize in and for which few treatments options exist, at least in part because of lack of funding. This experience led me to ask what lobbying strategies are effective specifically for interest groups that represent a single disease. Lobbying strategies are well studied, but less research has been done to examine the strategies used by interest groups representing smaller and very specific constituencies, such as those affected by a single disease.31 pagesen-USCollection may be protected under Title 17 of the U.S. Copyright Law. To obtain information or permission to publish or reproduce, please contact the Goucher Special Collections & Archives at 410-337-6347 or email archives@goucher.edu.Text